Mind your assays: Misleading cytotoxicity with the WST-1 assay in the presence of manganese.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 07 11 2019
accepted: 27 03 2020
entrez: 17 4 2020
pubmed: 17 4 2020
medline: 17 7 2020
Statut: epublish

Résumé

The WST-1 assay is the most common test to assess the in vitro cytotoxicity of chemicals. Tetrazolium-based assays can, however, be affected by the interference of tested chemicals, including carbon nanotubes or Mg particles. Here, we report a new interference of Mn materials with the WST-1 assay. Endothelial cells exposed to Mn particles (Mn alone or Fe-Mn alloy from 50 to 1600 μg/ml) were severely damaged according to the WST-1 assay, but not the ATP content assay. Subsequent experiments revealed that Mn particles interfere with the reduction of the tetrazolium salt to formazan. Therefore, the WST-1 assay is not suitable to evaluate the in vitro cytotoxicity of Mn-containing materials, and luminescence-based assays such as CellTiter-Glo® appear more appropriate.

Identifiants

pubmed: 32298350
doi: 10.1371/journal.pone.0231634
pii: PONE-D-19-31024
pmc: PMC7161962
doi:

Substances chimiques

Cytotoxins 0
Tetrazolium Salts 0
Manganese 42Z2K6ZL8P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0231634

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Physiol Genomics. 2002 Dec 26;12(1):13-23
pubmed: 12419857
Biomaterials. 2014 Dec;35(38):10009-14
pubmed: 25263686
Toxicol Appl Pharmacol. 2009 Jan 15;234(2):222-35
pubmed: 18983864
Nano Lett. 2005 Jun;5(6):1107-10
pubmed: 15943451
J Mater Sci Mater Med. 2013 Mar;24(3):713-24
pubmed: 23183963
BMC Res Notes. 2015 Feb 20;8:47
pubmed: 25884200
Acta Biomater. 2014 Jul;10(7):3346-53
pubmed: 24732635
J Biomed Mater Res A. 2010 Apr;93(1):1-11
pubmed: 19437432
Acta Biomater. 2010 May;6(5):1813-23
pubmed: 19837191
Acta Biomater. 2010 May;6(5):1680-92
pubmed: 20172057
Biomaterials. 2006 Oct;27(28):4955-62
pubmed: 16765434
Nano Lett. 2006 Jun;6(6):1261-8
pubmed: 16771591
Int J Toxicol. 2016 Jul;35(4):454-62
pubmed: 27207930
Nano Lett. 2005 May;5(5):897-900
pubmed: 15884890
Biotechnol Annu Rev. 2005;11:127-52
pubmed: 16216776
Br J Cancer. 1989 Oct;60(4):523-8
pubmed: 2529890
Mater Sci Eng C Mater Biol Appl. 2013 May 1;33(4):1882-93
pubmed: 23498209

Auteurs

Eleonora Scarcello (E)

Louvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Brussels, Belgium.

Alexia Lambremont (A)

Institute of Mechanics, Materials and Civil Engineering, Université catholique de Louvain, Louvain-la-Neuve, Belgium.

Rita Vanbever (R)

Advanced Drug Delivery & Biomaterials, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.

Pascal J Jacques (PJ)

Institute of Mechanics, Materials and Civil Engineering, Université catholique de Louvain, Louvain-la-Neuve, Belgium.

Dominique Lison (D)

Louvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH